3
Announcements
Trials
Browse
Landscape
Sponsor
Cancer Type
Other hematologic neoplasm
182
Lymphoid
162
Myeloid
74
Plasma cell
50
Dermatologic
30
Classical hematology
21
Sarcoma
13
Gynecologic
12
Genitourinary
12
Breast
10
Thoracic
6
Gastrointestinal
6
CNS
6
Head & Neck
3
Tumor-Agnostic
2
Other solid neoplasm
1
Interventions
Everolimus
18
lanreotide
7
Octreotide
7
pembrolizumab
6
Sunitinib
6
Magnetic Resonance Spectroscopy
5
lutetium Lu 177 dotatate
4
gallium Ga 68 dotatate
4
cabozantinib
4
Nivolumab
4
Carboplatin
4
telotristat ethyl
3
pasireotide
3
lenvatinib
3
arginyllysine
3
Temozolomide
3
Specimen Handling
3
Etoposide
3
Erlotinib Hydrochloride
3
Bevacizumab
3
surufatinib
2
pazopanib
2
amino-acid, glucose, and electrolyte solution
2
X-Rays
2
Sorafenib
2
Phantoms, Imaging
2
Paclitaxel
2
Oxaliplatin
2
Ipilimumab
2
Doxorubicin
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
fludarabine
×
NET
×
Clear all
No trials found.